Health
-
An exercise drug?
Researchers hope to harness the cognitive benefits of a workout for Alzheimer’s patients with mobility issues
-
-
Got emotional wellness app? It may be doing more harm than good.
Study sees mental health risks, suggests regulators take closer look as popularity rises amid national epidemic of loneliness, isolation
-
Why are young people taking fewer risks?
Psychologist describes generation overparented — but also overwhelmed by ‘frightening world’
-
What might cancer treatment teach us about dealing with retinal disease?
Joan Miller’s innovative thinking led to therapies for macular degeneration that have helped millions, made her better leader
Part of the Profiles of Progress series -
Cuts imperil ‘keys to future health’
Project has tracked lives, lifestyles, and well-being of cohorts over decades, led to insights, interventions in cardiovascular disease, cancers, nutrition
-
Is a mobile app as good as a therapist?
A closer look at the mental health apps that claim to treat depression, anxiety, and other mental illnesses.
-
The COVID treatment that missed its target
“Monoclonal antibodies should first go to patients at the highest risk of death from COVID-19, but the opposite happened …, ” says a Harvard Chan School researcher.
-
Is Omicron really ‘milder’? Not exactly.
The “milder” outcomes of Omicron are likely due to more population immunity rather than the virus’ properties, according to new research.
-
Willing but unable to get COVID shot
Mistrust of vaccine is high among people of color in U.S. and U.K., but unequal access appears to be greater barrier in U.S., researchers say.
-
Research suggests role for anthrax in fighting pain
In search for alternatives to opioids, Medical School researchers have hit on an unlikely candidate.
-
Vitamin D supplements lower risk of autoimmune disease, researchers say
A new study finds vitamin D supplements with or without omega-3s decreased the risk of autoimmune diseases by 22 percent compared to placebo.
-
Hanage and other scientists keep close watch on Omicron subvariant
As Omicron rapidly recedes, some countries are seeing a new version of the variant, dubbed BA.2
-
Race still a factor in air pollution exposure
A new Harvard study has found that racial, ethnic minorities, and low-income groups in U.S. are exposed to higher levels of air pollution.
-
Study explores possible autism link in young adults treated for addiction
One in five youths with substance-use disorders may have undiagnosed autistic traits, say researchers.
-
Exploring why some remain sharp even as decades roll by
Harvard researchers study “super-aging” minds for clues to possible interventions for the rest of us.
-
Comparison of male, female classroom behavior reveals assertiveness gap
A new study finds that women and men physicians participate differently in academic settings, potentially contributing to gender biases that disadvantage female students.
-
How the pandemic may affect baby’s brain
For babies born during this pandemic, a study published in JAMA Pediatrics suggests their brains may not fully develop.
-
Omicron optimism and shift from pandemic to endemic
With Omicron on the decline in some states, pandemic experts permit themselves hope, at least for the near term.
-
Why do more men die of COVID? It’s likely not what you think
Sex differences in COVID death rates vary by state and across time, suggesting social factors play a role.
-
Delta danger in pregnancy scrutinized
Researchers detect the COVID-19 variant in the blood and placentas of women who had stillbirths and pregnancy complications.
-
Add olive oil to cut risk of early death, study suggests
Harvard Chan School researchers see impact in cardiovascular and respiratory conditions, cancer, and neurodegenerative disease.
-
Epstein-Barr virus may be leading cause of MS
Multiple sclerosis is likely caused by infection with the Epstein-Barr virus, according to a study led by Harvard T.H. Chan School of Public Health researchers.
-
Study identifies potential test for cannabis impairment
Researchers have found a noninvasive brain imaging procedure to be an objective and reliable way to identify individuals whose performance has been impaired by THC.
-
Healthy? Maybe. But are you flourishing?
Researchers at Harvard, Baylor launch groundbreaking Global Flourishing Study.
-
No Omicron immunity without booster, study finds
Traditional dosing regimens of COVID-19 vaccines available in the United States do not produce antibodies capable of recognizing and neutralizing the Omicron variant, reports a new study.
-
‘Schools should not close’
Harm to kids and families outweighs COVID risks, says Harvard Chan School expert Joe Allen.
-
Omicron could peak in U.S. fairly soon. Maybe.
Experts say fast-spreading, less severe profile of Omicron is emerging as cases drop in South Africa but warn of challenging weeks ahead.
-
Study holds warning on pandemic drinking
A one-year increase in alcohol consumption in the U.S. during the COVID-19 pandemic is estimated to cause 8,000 additional deaths from alcohol-related liver disease by 2040.
-
Your best, worst traits: Was it something mom did while pregnant?
Sarah Richardson traces history of debate over lasting effects of maternal behaviors, experiences on gestating offspring.
-
Cancer clues in a drop of blood
A new study provides proof-of-concept for the ability of a drop of blood to reveal lung cancer in asymptomatic patients.
-
Remdesivir-resistant COVID case sets off few alarms
Harvard Med specialist says cases of remdesivir-resistant disease seem rare, may not become big issue.
-
Fauci speaks to the perilous moment in Harvard Chan School lecture
At Harvard, Anthony Fauci outlined early Omicron findings and urged more robust efforts to bring the pandemic under control, including global vaccination.
-
Scientists race to define Omicron threat, worried about ‘surge upon a surge’
Early findings on immune escape and transmissibility, combined with danger posed by Delta, heighten urgency of vaccination, testing, other safety measures.
-
2 early vaccination surveys worse than worthless thanks to ‘big data paradox,’ analysts say
As governments and health officials navigate pandemic, researchers stress the danger that comes with bad information.
-
Time of day matters when getting vaccine
An observational study finds that antibody levels are higher when health care workers received the SARS-CoV-2 vaccine in the afternoon.